Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Adenosine-5'-(Dithio)Phosphate
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
Adenosine-5'-(Dithio)Phosphate is a small molecule consisting of an adenosine moiety linked to a dithiophosphate group. It has a molecular formula of C10H14N5O5PS2 and a molecular weight of approximately 379.4 g/mol. The compound is not approved for any specific medical conditions and lacks detailed clinical trial data[1][2][3].
- Other names
- 9WPM6R7Z7QADENOSINE-5'-(DITHIO)PHOSPHATE(((2R,3S,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl)methoxy)(hydroxy)sulfanyl-lambda5-phosphanethione{[(2R,3S,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)sulfanyl-lambda5-phosphanethioneSCHEMBL21067563SCHEMBL-21067563SCHEMBL 21067563
Beyond the preview
Go deeper on Adenosine-5'-(Dithio)Phosphate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Adenosine-5'-(Dithio)Phosphate.